Jay Martin: Early Stage Investing In Public Companies – The Daily Dive

For this weeks final episode of The Daily Dive, we sit down with Jay Martin of Cambridge House (CambridgeHouse.com). Jay joins us this afternoon to discuss Cambridge House and their specialties, investing in early stage companies, and performing due diligence to lead to a better performing portfolio.

Cambridge House is focused on conducting Canada’s leading junior mining conference, which has lead the firm to becoming a well-recognized name in public venture capital. The firm today conducts some of the largest investor conferences in the fields of both natural resources and technology.

Catch the full interview below.


The author has no securities or affiliations related to any organization mentioned. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

First Phosphate Gains Danish State Support With LOI For EUR 170 Million Credit Guarantee

Denarius Metals Offers To Acquire Emerita At Just $0.30 A Share

Related News

SpotGamma: Understanding Gamma Squeezes – The Daily Dive

Today on the Daily Dive, we sit down with someone who has become a frequent...

Tuesday, February 23, 2021, 01:30:00 PM

Highest Grade Antimony Mine in the World!? | James Atkinson – Antimony Resources

Jim Atkinson, CEO of Antimony Resources Corp. (CSE: ATMY), breaks down what's happening with China's...
Saturday, August 9, 2025, 09:34:00 AM

Nuclear Energy Powers AI Ambitions with Richard Homsany of Toro Energy

In this interview, Richard Homsany, Executive Chairman of Toro Energy (ASX: TOE), provides insights into...

Wednesday, October 2, 2024, 02:54:00 PM

Aztec Minerals: Drill Results Continue To Expand California Zone – The Daily Dive

Today on the Daily Dive, we sit down with Simon Dyakowski, President and CEO of...

Monday, April 25, 2022, 01:30:00 PM

A Heart Disease Cure For Pericarditis? Phase 3 Trial Advances | David Elsley – Cardiol Therapeutics

Discover the major breakthrough at Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL) as CEO David Elsley...
Saturday, April 26, 2025, 11:38:00 AM